| A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9 (NCT02946606) | Genexine, Inc. | 2015-01-01 |
| FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI (NCT02255305) | Endeavor Health | 2015-01-01 |
| Alendronate to Prevent Loss of Bronchoprotection in Asthma (NCT02230332) | Milton S. Hershey Medical Center | 2015-01-01 |
| Re-irradiation for Pelvic Recurrences in Rectal Cancer Patients (NCT05816980) | Aarhus University Hospital | 2015-01-01 |
| Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity (NCT02281006) | CHU de Quebec-Universite Laval | 2015-01-01 |
| Misoprostol Prior to Office Hysteroscopy in Patients With no Risk Factors for Experiencing Unacceptable Pain (NCT02318225) | Cairo University | 2015-01-01 |
| The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency (NCT02498327) | University of Johannesburg | 2015-01-01 |
| A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET) (NCT02288377) | Federation Francophone de Cancerologie Digestive | 2015-01-01 |
| Thiamine as an Adjunctive Therapy in Cardiac Surgery (NCT02322892) | Beth Israel Deaconess Medical Center | 2015-01-01 |
| Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer (NCT02350517) | Yuhong Li | 2015-01-01 |
| Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer (NCT02337712) | Sun Yat-sen University | 2015-01-01 |
| Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study (NCT02804360) | Rafic Hariri University Hospital | 2015-01-01 |
| Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin (NCT02387203) | Mercy Medical Center | 2015-01-01 |
| A Comparative Study of Intrathecal Magnesium Sulphate & Midazolam With Epidural Ropivacaine for Caesarean Patients (NCT02619799) | Rangaraya Medical College | 2015-01-01 |
| Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD (NCT02824653) | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 2015-01-01 |
| A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations (NCT02283177) | Arog Pharmaceuticals, Inc. | 2015-01-01 |
| A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma (NCT02423343) | Eli Lilly and Company | 2015-01-01 |
| Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL (NCT02212379) | ANRS, Emerging Infectious Diseases | 2015-01-01 |
| A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer (NCT02260440) | Anuradha Krishnamurthy | 2015-01-01 |
| Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children (NCT02339350) | The Korean Society of Pediatric Hematology Oncology | 2015-01-01 |
| Therapeutic Management of Complex Anal Fistulas by Installing a Closure Clip: Multicentre Randomized Controlled Trial (NCT02336867) | University Hospital, Clermont-Ferrand | 2015-01-01 |
| The Efficacy of an Acupuncture Protocol and Use of Taping in the Treatment of Spastic Upper Limb After Stroke (NCT02690493) | Fernanda Cechetti | 2015-01-01 |
| Triple DAAs Regimen in Treating Non-cirrhotic HCV GT1b Subjects (NCT02470858) | Humanity and Health Research Centre | 2015-01-01 |
| Cold Contact Urticaria Treatment With Rilonacept (NCT02171416) | Charite University, Berlin, Germany | 2015-01-01 |
| 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies (NCT02348749) | Memorial Sloan Kettering Cancer Center | 2015-01-01 |
| A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse (NCT02330991) | Beijing Sanbo Brain Hospital | 2015-01-01 |
| Carnitine for the Treatment of Atherosclerosis. (NCT02117661) | Dr. Amer Johri | 2015-01-01 |
| Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia (NCT02304770) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2015-01-01 |
| The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer (NCT02347956) | Yonsei University | 2015-01-01 |
| Reversal of Dabigatran With Prothrombin Complex Concentrate (NCT02463591) | University Medical Center Groningen | 2015-01-01 |
| The Role of TLR4 on Lipid-induced Insulin Resistance (NCT02321111) | The University of Texas Health Science Center at San Antonio | 2015-01-01 |
| A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants (NCT02268864) | Janssen-Cilag International NV | 2015-01-01 |
| Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia (NCT02407470) | Navy General Hospital, Beijing | 2015-01-01 |
| A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors (NCT02322853) | Centre Francois Baclesse | 2015-01-01 |
| Early Use of Opioid in Radiation Mucositis (NCT02309437) | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 2015-01-01 |
| A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous Leukemia (NCT02287233) | AbbVie | 2014-12-31 |
| Study of Acetaminophen (ACE) in Post-operative Dental Pain (NCT02320708) | Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. | 2014-12-31 |
| A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate (NCT04192617) | SinoMab BioScience Ltd | 2014-12-31 |
| Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer (NCT02152137) | Alliance for Clinical Trials in Oncology | 2014-12-30 |
| 1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma (NCT02289222) | Ashraf Badros | 2014-12-30 |
| Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART (NCT01903031) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-12-30 |
| Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure (NCT02235077) | Duke University | 2014-12-30 |
| FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression (NCT02325739) | Novartis Pharmaceuticals | 2014-12-29 |
| Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab (NCT02338245) | ASLAN Pharmaceuticals | 2014-12-29 |
| A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer (NCT01823835) | Genentech, Inc. | 2014-12-29 |
| Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma (NCT02432274) | Eisai Limited | 2014-12-29 |
| Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma (NCT02180711) | Acerta Pharma BV | 2014-12-29 |
| Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC) (NCT02343978) | Kissei Pharmaceutical Co., Ltd. | 2014-12-26 |
| Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival (NCT02364557) | NRG Oncology | 2014-12-24 |
| Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee (NCT02554240) | Dong-A ST Co., Ltd. | 2014-12-23 |
| SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) (NCT02258152) | Biotie Therapies Inc. | 2014-12-22 |
| Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes (NCT02286687) | M.D. Anderson Cancer Center | 2014-12-22 |
| Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention (NCT02315703) | Janssen Vaccines & Prevention B.V. | 2014-12-22 |
| Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD (NCT02322190) | National Cancer Institute (NCI) | 2014-12-20 |
| Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies (NCT02328014) | Acerta Pharma BV | 2014-12-20 |
| Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer (NCT02263495) | Asan Medical Center | 2014-12-19 |
| BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer (NCT03627390) | Meabco A/S | 2014-12-19 |
| Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin (NCT02359474) | Ludwig-Maximilians - University of Munich | 2014-12-19 |
| Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma (NCT02243605) | National Cancer Institute (NCI) | 2014-12-19 |
| A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection (NCT02292719) | AbbVie | 2014-12-19 |
| A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers (NCT02371889) | University of Pennsylvania | 2014-12-18 |
| Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer (NCT02291913) | SCRI Development Innovations, LLC | 2014-12-18 |
| LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis (NCT02098161) | M.D. Anderson Cancer Center | 2014-12-18 |
| A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI (NCT02182440) | AM-Pharma | 2014-12-18 |
| Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer (NCT03048942) | University Hospitals Bristol and Weston NHS Foundation Trust | 2014-12-18 |
| Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years (NCT02276872) | United Therapeutics | 2014-12-18 |
| The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) (NCT02269267) | Medical College of Wisconsin | 2014-12-18 |
| MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (NCT01910259) | University College, London | 2014-12-18 |
| Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy (NCT02115464) | Ontario Clinical Oncology Group (OCOG) | 2014-12-17 |
| 12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks (NCT02303626) | BioCryst Pharmaceuticals | 2014-12-17 |
| Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS) (NCT01978535) | Mayo Clinic | 2014-12-17 |
| A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer (NCT02488564) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2014-12-17 |
| Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer (NCT02294786) | Novartis Pharmaceuticals | 2014-12-17 |
| Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA) (NCT02379091) | Takeda | 2014-12-17 |
| Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma (NCT02290431) | Novartis Pharmaceuticals | 2014-12-16 |
| Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein (NCT02465801) | Tianjin SinoBiotech Ltd. | 2014-12-16 |
| Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT02152982) | National Cancer Institute (NCI) | 2014-12-15 |
| A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT02289833) | Hoffmann-La Roche | 2014-12-15 |
| Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose (NCT02157987) | University Hospital, Caen | 2014-12-15 |
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (NCT02292758) | Academic and Community Cancer Research United | 2014-12-12 |
| E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma (NCT02279394) | Dana-Farber Cancer Institute | 2014-12-11 |
| Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery (NCT02178241) | National Cancer Institute (NCI) | 2014-12-11 |
| 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS) (NCT02328027) | Advanced Accelerator Applications | 2014-12-11 |
| Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects (NCT02342249) | Janssen Research & Development, LLC | 2014-12-11 |
| A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma (NCT02255110) | Merck KGaA, Darmstadt, Germany | 2014-12-10 |
| Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT02299375) | GlaxoSmithKline | 2014-12-09 |
| Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma (NCT02181634) | PrECOG, LLC. | 2014-12-09 |
| Dose Range Finding Study of Bimagrumab in Sarcopenia (NCT02333331) | Novartis Pharmaceuticals | 2014-12-09 |
| Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies (NCT02214160) | Ultragenyx Pharmaceutical Inc | 2014-12-09 |
| Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT (NCT02349178) | Medical College of Wisconsin | 2014-12-08 |
| Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly (NCT02298582) | University Hospital, Grenoble | 2014-12-08 |
| Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation (NCT02273739) | Celgene | 2014-12-08 |
| Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) (NCT02315326) | Memorial Sloan Kettering Cancer Center | 2014-12-08 |
| Botulinum Toxin A to Treat Arm Tremor (NCT02207946) | Merz Pharmaceuticals GmbH | 2014-12-05 |
| Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction (NCT02287129) | Technical University of Munich | 2014-12-05 |
| A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis (NCT03114254) | University Hospitals Bristol and Weston NHS Foundation Trust | 2014-12-05 |
| Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants (NCT02302066) | Takeda | 2014-12-05 |
| Topical Raplixa for Surgical Bleeding in Children (NCT02117349) | Mallinckrodt | 2014-12-04 |
| Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma (NCT02179086) | NRG Oncology | 2014-12-04 |
| Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia. (NCT01641107) | Incyte Corporation | 2014-12-04 |